| Lisa Marie Rhodes, MD | |
|
8825 Bee Caves Rd Ste 100, Austin, TX 78746-4721 | |
| (512) 328-3376 | |
| (512) 540-4626 |
| Full Name | Lisa Marie Rhodes |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 8825 Bee Caves Rd Ste 100, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326011859 | NPI | - | NPPES |
| 8M7130 | Other | TX | BCBS OF TEXAS INDIVIDUAL # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | L8919 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westlake Dermatology Pa | 6305817230 | 40 |
News Archive
Some studies indicate that early life exposure to pollutants such as PCBs and phthalates can predispose people to disease. Now environmental scientist Alicia Timme-Laragy at the University of Massachusetts Amherst has received a five-year, $1.7 million grant from the National Institute of Environmental Health Sciences for a multi-level study of early life exposure to environmental contaminants and aberrant pancreas development, which may predispose one to diabetes.
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions.
Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together important steps in how Parkinson's disease (PD) spreads from cell to cell and leads to nerve cell death.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
› Verified 5 days ago
| Entity Name | Westlake Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518939347 PECOS PAC ID: 6305817230 Enrollment ID: O20040804000774 |
News Archive
Some studies indicate that early life exposure to pollutants such as PCBs and phthalates can predispose people to disease. Now environmental scientist Alicia Timme-Laragy at the University of Massachusetts Amherst has received a five-year, $1.7 million grant from the National Institute of Environmental Health Sciences for a multi-level study of early life exposure to environmental contaminants and aberrant pancreas development, which may predispose one to diabetes.
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions.
Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together important steps in how Parkinson's disease (PD) spreads from cell to cell and leads to nerve cell death.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Marie Rhodes, MD 8825 Bee Caves Rd Ste 100, Austin, TX 78746-4721 Ph: (512) 328-3376 | Lisa Marie Rhodes, MD 8825 Bee Caves Rd Ste 100, Austin, TX 78746-4721 Ph: (512) 328-3376 |
News Archive
Some studies indicate that early life exposure to pollutants such as PCBs and phthalates can predispose people to disease. Now environmental scientist Alicia Timme-Laragy at the University of Massachusetts Amherst has received a five-year, $1.7 million grant from the National Institute of Environmental Health Sciences for a multi-level study of early life exposure to environmental contaminants and aberrant pancreas development, which may predispose one to diabetes.
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions.
Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together important steps in how Parkinson's disease (PD) spreads from cell to cell and leads to nerve cell death.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
› Verified 5 days ago
Dr. John Joseph Ghidoni Iii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8229 Shoal Creek Blvd, Suite#101, Austin, TX 78757 Phone: 512-371-7400 Fax: 512-371-7488 | |
Moise Levy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 200, Austin, TX 78723 Phone: 512-628-1920 Fax: 512-628-1921 | |
Dr. Susan Elizabeth Dozier, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8240 N Mo Pac Expwy, Suite 355, Austin, TX 78759 Phone: 512-527-9020 Fax: 512-527-9000 | |
Dr. Gregory A. Nikolaidis, Dermatology Medicare: Medicare Enrolled Practice Location: 8825 Bee Cave Rd, Suite 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-399-6895 | |
Amy Ayres Mcclung, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9701 Brodie Ln Ste 106, Austin, TX 78748 Phone: 512-280-3939 Fax: 512-280-3938 | |
Stanley Tyler Hollmig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1601 Trinity St Ste 704b, Austin, TX 78712 Phone: 512-324-7468 Fax: 512-324-7469 | |
Dr. Lauren Piilani Rimoin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8825 Bee Caves Rd Ste 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-666-3767 |